SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (21264)4/23/1999 4:08:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
DaiS,

From what I understand it has nothing to do with whether "MUSE works". Not going to waste my time beating that dead short horse. I think it has a lot to do with the power struggle at the top and actually has nothing to do with the merits of MUSE/Alibra. It is corporate politics and not product fundamentals that is slowing things down. Can't blame Lee for that.

VLAD



To: DaiS who wrote (21264)4/23/1999 4:23:00 PM
From: RT  Read Replies (1) | Respond to of 23519
 
Dias,

Where did you hear about this internal conflict?
Maybe Zeneca just doesn't wish to waste the time marketing a product which will be made obsolete by Alibra in less than 12 months.
Alibra has such a distinct advantage over Muse it might be wise to wait.
1. One titration
2. Smaller applicator
3. No burning ?
4. No refrigeration
5. Lower cost per unit
6. More effective

RT


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News